chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Employee felt like headed pretty soon after vaccine and had never experienced that feeling before. He has had no reactions like this in the past. He was evaluated by EMS and was tachycardic and hypertensive at first. Blood pressure and tachycardia normalized. He reports his baseline heart rate is on the higher end. He was monitored for a total of about 30 minutes and felt back to baseline after he was evaluated.
I received vaccine early after evening my arm started to swell. Then, fever and chills. Next day-fever and arm was red and swollen. Next day-red and swollen from upper arm to elbow. Lasted 4 days.
Shortly after receiving vaccination, patient turned pale and lost consciousness in his chair for about 1 minute. Patient regained consciousness and started sweating. Orange juice was provided per patient request as he reported having symptoms similar to having low blood sugar. Patient was advised to remain in the pharmacy until he feels better and routinely checked by a pharmacist and pharmacy intern. After sitting down for about 45 minutes, patient reported feeling better and left pharmacy.
the upper part of her left arm is swelling and turning to red. very itchy and when the swelling arm is pressed manually, she can feel the pain
red erythematous rash with fine macules only at the site of injection. About 2" diameter lasted 10-12 days
44 year old female into clinic on 02/25/2019 for TDaP vaccine. Client's daughter will be having baby. Client was a little apprehensive about injection, because does not like injections, and she had started antibiotics for tooth infection before having teeth pulled. Client concerned that she might have a reaction because of antibiotics. PHN explained that per our guidelines and VIS statement that should not have a problem. Client asked if wanted injection or wanted to wait, but agreed to have injection. She had watched daughter get injection and said that just watching this made her feel funny. TDaP given in Left Deltoid at 4:10 PM, client stated that she felt sick, and lightheaded. PHN assisted client to lie down on exam table. Lowered head and tool BP 140/88 at 4:15PM, client skin cool and clammy and flushed neck and face. BP 150/90 at 4:30PM continued to have nausea if tried to elevate head, BP 143/88 at 4:45 given juice, flushing of face and neck began to diminish. Offered to call EMS but client does not have insurance. BP140/88 at 5:00PM, BP 136/84 at 5:15PM, and gradually elevated head. BP126/74 at 5:30PM and client was able to stand and walked out of clinic with family. PHN called 02/26/2018 to check on client, talked with aunt and said client was still feeling a little weak, still questioned if TDaP should have been given with antibiotics.
where she's had the fillers, she was swollen and it's very painful; fever; body aches; chills; too sick to get out of bed; This is a spontaneous report from a contactable nurse (patient herself). A 27-year-old female patient, not pregnant, received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscularly on the left arm, on 04Feb2021 16:15, at single dose, for covid-19 immunization. Medical history included having had fillers before. Concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) on an unknown date at 27-years-old for covid-19 immunization. The vaccine was received at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. She was not diagnosed with COVID-19 prior to vaccination. She stated having had fillers before and now where she's had the fillers, she was swollen and it's very painful. This was also besides the fever, body aches, and chills she has. As for the lot number of the vaccine, she was too sick to get out of bed to look for it. All the adverse events happened on 05Feb2021. The outcome of all the adverse events was unknown. The patient has not been COVID-19-tested post-vaccination.   Information about the lot/batch number has been requested.
There was a circular line of black dots about an inch in circumference around the injection site - looked like a tattoo. (I took a picture today the 17th) and further down my arm I had two larger reddened and warm swollen painful areas. I have a swollen painful lymph node at my left clavicle. Haaedache and fatigue on the 15th. No fever. Today the 17th, the reddend areas have gone down. The "tattooing" is still surrounding the injection site, headache and fatigue are gone.
Sudden High blood pressure.  Treated with amlodipine-valsartan.
This spontaneous report received from a registered nurse referred to a 1 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-MAR-2017, the patient was vaccinated with VARIVAX (dose, frequency not reported, lot:M035142, expiry date not reported) for an unspecified indication. The nurse reported that the vaccines were stored in a freezer with defrost cycles, but full excursion details were not provided (incorrect product storage). The reason for the temperature excursion occurred was due to the defrost cycle of the freezer. The nurse was unable to provide the lot number and expiration date for the properly stored sterile diluent that may have been used to reconstitute the vaccine. No adverse effects reported. The temperature for the vaccine stored and time frame was unspecified. Previous temperature excursion was unspecified. Data logger was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Amenorrhea. No menses since July 2021, previously regular cycles every 28-35 days for >1 year
Administration error - Provided vaccines without a provider agreement under the Dept of Health. Transported vaccines in sandwich cooler and no temp checks.
This 12-month old boy was seen for routine well child visit on 6/23/11 and given PENTACEL, MMR, Varicella, Hepatitis A vaccine and PPD test. That evening, he developed hives. He was brought to the ER on 6/24/11, given IV Diphenhydramine & sent home on P.O. Diphenhydramine; no fever; no difficulty breathing or swallowing.
Hospitalized 12/8/2021; COVID-19 positive 12/8/2021; fully vaccinated  Discharge Provider: (NAME), MD Primary Care Provider: (NAME), FNP Admission Date: 12/8/2021 Discharge Date: Dec 20, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus    HOSPITAL COURSE:   74 y.o. male with HX of prostate Ca, HTN, and HLD who presents with complaint of profound fatigue and intermittent chills since November 30th. Patient was found to have COVID 19 infection , he was Hypoxic and was placed on 4 L NC, CXR showed bilateral basilar opacity , patient is Vaccinated but no boosted , he was transferred from a local ED to a local hospital , treated with Decadron and Remdesivir , O2 requirements increased to 5-6L , patient significantly desaturates with ambulation, repeat xray showed no changes or worsening , CRP and D-Dimer was appropriately trending down , he received one dose on IV lasix without significant response .    He continues to remain stable but felt minimal improvement despite remdesivir and decadron.  He continues to desaturate with activity with uptrending D-dimer , CTA Showing no pulmonary embolism but positive for COVID pneumonitis.  He was then transitioned to IV Solu-Medrol 40 mg IV 2 times a day, azathioprine . O2 saturation improved , patient did not desat with activity on 6 L , pulmonary rehab arranged for Home Oxygen , he will need 4 liters at rest and 6 liters with activity.  He will be on prolonged steroid taper . Patient will be signed up with COVID at home program and will need follow up with PCP within 1 week.  Patient was discharged in stable condition.
Information has been received from a physician concerning a 23 month old female pt with a history of "imperforated anus s/p reconstruction, 8/01" who on 04/09/02 was vaccinated SC in the left thigh with a first dose of varicella virus vaccine live (Lot # 640823/1154L).  There was no illness at the time of vaccination.  Concomitant therapy on 04/09/02 included a SC first dose in the left thigh of MMRII (Lot # 640963/1379L) and an IM second dose in the right thigh of Haemophilus B conjugate vaccine + hepatitis B recombinant (yeast) vaccine (Lot # 639126/0348L).  On 03/12/2003, the pt developed a chickenpox rash, described as a papular-vesicular rash with 12 lesions total that were crusted over within 48 hours.  It was noted that the child was mildly pruritic, there was no fever and no other symptoms were noted.  There was no relevant diagnostic lab data.  It was also noted that she was not ill at the time, but was in the office with another sibling that was ill. Unspecified medical attention was sought. Subsequently, the pt recovered on 03/14/03.  There was no product quality complaint involved. The physician also reported on two other siblings that developed chickenpox (WAES # 0303USA02487 & WAES # 0303USA02488).  No further information is expected.
I had the typical initial side effects, malaise, mild headache, lack of appetite and these seemed to resolve quickly.  9 days later the malaise, headache and lack of appetite returned with the addition of 99.4 fever.  Those symptoms again resolved in about a day.   At day 12, malaise and headache returned with the addition of brief vomiting, diarrhea and 101.2 fever
Information has been received from a physician concerning a 4-month-old male who on 23-JUL-2007 was vaccinated with the second dose of ROTATEQ (Lot #657514/0667U). The physician reported that on 31-JUL-2007, the patient developed bloody emesis, loose stools and intermittent crying bouts. The patient's stool was tested and no blood was seen. At the time of this report, the outcome was unknown. Additional information has been requested.
Delayed (8 weeks) onset red raised rash, exfoliating. Biopsy at dermatologist. Dx ? erythema annularis centralfugum.
I experienced chest pain while laying on side with each beat ( Myocarditis/pericarditis). I went to the ER and was admitted to the hospital for a full cardiac workup. It resolved itself after approximately one to two week. My cardiologist did not feel the need to do a stress test since an angiogram was performed. I was advised that if the chest pain came back I have a prescription for Colchicine as a precaution and I did not have to get the prescription fill (emergency purposes only since the medication has significant side effects).
Day of vaccine: waiting a few hours, I started feeling aches and pains, with bad pain at the injection site. By 10 PM, I had a low fever (100) and felt exhausted and weak. Tossed and turned all night, waking up chattering with cold, then burning hot. The next morning, I had a temperature of 101, where it  hovered throughout the day, going up to 101.7 at the highest measured. The whole day I was completely wiped out with worsened aches and pains, and now also stiffness, especially in my neck (where I do have issues) and in my back (where I do not have issues). All I could really do is sleep all day. On the recommendation of my doctor's office, I took Aleve. That night I slept much better, and woke up with a lower fever (100). I am continuing to feel better.
10/12/2011 onset of all over itching sensation.  No rash or redness noted.
Inappropriate schedule of vaccine administered; Vaccine exposure during pregnancy; First dose of vaccine administered after excursion; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 11-Mar-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 11-Mar-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (First dose of vaccine administered after excursion) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The treatment information was not given.   This case was linked to MOD-2021-250576 (Patient Link).   Reporter did not allow further contact
10 mcg of Moderna bivalent vaccine given instea dof 25 mcg dose
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Sep2022 at 08:30 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 54 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for 1 day, as dose 2, single (Batch/Lot number: unknown) for 1 day, as dose 3 (booster), single (Batch/Lot number: unknown) for 1 day and as dose 4 (booster), single (Batch/Lot number: unknown) for 1 day for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ALLOPURINOL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 27Sep2022, outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Sep2022) Positive; (05Oct2022) Negative; (08Oct2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Paxlovid was received as treatment for COVID-19 from 28Sep2022 to 03Oct2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Approximately 48 hours after shot hives appeared on arms. The next day they were larger and are on neck, arms, torso, and legs.; This is a spontaneous report received from a contactable consumer (patient). A 14-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COIVD-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0186), via an unspecified route of administration, administered in arm left on 27May2021 at 13:15 (at the age of 14-year-old) as single dose for COVID-19 immunisation. Medical history included Wolf Parkinson White syndrome, ADHD, ODD, mold allergy, pollen allergy and pet dander allergy. Concomitant medications included atomoxetine hydrochloride (STRATTERA), fluoxetine, montelukast and hydroxyzine. Patient was not diagnosed with COVID prior to vaccination and was not tested for COVID since the vaccination. On 29May2021, approximately 48 hours after shot hives appeared on arms, the next day they were larger and are on neck, arms, torso, and legs. Patient did not receive any treatment for the adverse event. The outcome of the event was resolving.
biopsy-proven disseminated Zoster. treated with valacyclovir, responding well.
pt recv vax 1AUG95 & 8JUN97 pt devel very mild breakthrough chickenpox w/lesions on eyelids, nose & lips;
Pt recvd pneumovax 23 on 16MAR91; This dosage was repeated on 18MAR91; @ time of the report, no adverse exp had occurred;
5hr post vax pt started having trouble breathing & started turning blue;also had a temp of 100.9;pt was seen by MD & no tx given;
patient reports lacey rash to left upper arm s/p approximately 7 days after 1st dose of moderna; itching; still present today; reports localized swelling and firmness to area at day 7 but has since resolved
Site of injection became very red and raised up - about three inches in diameter. Not itchy.  This happened in about 24 hours after injection.
Chills,low grade fever for 2 days,body pain from neck to knees for 7 days. Some pain still exists but is getting better.
Pt had a fever, cough, and shortness of breath and was found to be COVID-19 positive. She was admitted with acute on chronic systolic heart failure and acute respiratory failure.
This spontaneous report was received from a registered nurse refers to a patient of unknown age. The medical history, concurrent conditions and concomitant medications were not reported. On 26-OCT-2016, the patient was vaccinated with a dose of improperly stored VARIVXA lot # M027347 01-JUN-2018 and M-M-R II, M032153 22-APR-2017. No adverse effects were reported. Additional information has been requested.
I have an extremely heavy period now, I woke up and there was a huge blood clot in my underwear and I literally gushed blood I?ve never seen that in all my 27 years of living and I?m afraid of what the next few days of my period will be like.
Muscle and nowhis arm is so sore that he isn't able to lift it; muscle and now his arm is so sore that he isn't able to lift it; This is a spontaneous report from a non-contactable consumer (patient).  This male patient (age not provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown), via an unknown route, on unknown date at single dose for COVID-19 immunization. No relevant medical history and concomitant medications were provided. The patient started that the nurse who gave him the shot put it in the muscle and now muscle and nowhis arm is so sore that he isn't able to lift it. Patient was reportedly "threatening a lawsuit" due to his experience. The outcome of the events was unknown.  No follow up attempts are possible; information on Lot/batch cannot be requested.
tired; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: EUFLEXXA (Euflexxa injections) and CORTIZONE [HYDROCORTISONE] (cortizone shot). Concurrent medical conditions included Drug allergy (suprex), Drug allergy (ceclor) and Joint disorder NOS (Improvement with cortizone shot and Euflexxa injections) since 24-Nov-2020. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), HYDROXYZINE EMBONATE (VISTARIL [HYDROXYZINE EMBONATE]), HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), ROSUVASTATIN CALCIUM (CRESTOR) and LORAZEPAM (ATIVAN) for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included benadryl 2 hours before shot.
Starting about 3 am following second covid vaccine shot at 1 pm day prior, developed muscle aches in back and legs, chills, dizziness, nausea, headache.  Also had pain in right arm at injection site about 4 hours after received vaccine.
received 1st shot of Singrix 21 months ago and did receive 2nd dose yet.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 89-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 21 months ago, batch number - 3HX44, expiry date - 15 November 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Flu shot (seasonal) about 3 PM (9-15-09) awoke 645 AM (9-16-09) with discomfort - after getting up I had severe fast heart beat and weak left arm from 6:45 Am till 9:15 AM. I called DR. office about 9:30 AM and they called me back about 12:30 pm. I called then twice in the morning. The med. assistant said Dr recommended BENADRYL and I guess I should have gone to ER
Approximately 24 hours after receiving the vaccine, I experienced extreme nausea and vomiting, diarrhea, lightheadedness/dizziness, and migraine. Symptoms began on Wednesday 12/30/2020 and lasted until Saturday 01/02/2021 after I called my primary care physician who prescribed Imodium and Zofran to help with the Diarrhea and Nausea/Vomiting. Symptoms lessened and around Monday  010/04/2021 I was able to keep fluids down and felt better overall.
no adverse effects; intramuscular route in error; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.   On 24-JUL-2019, the patient received a dose of vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live albumin status rHA (recombinant Human albumin) (M-M-R II) via intramuscular route in error, lot # R036582, expiration date 17-DEC-2020 (exact dose, frequency and anatomical location were not reported) for prophylaxis. Concomitant therapies included sterile diluent (DILUENT MRK). No adverse effects were reported.
Pt experienced fever 1 hr after receiving vax.24 hrs after vax, pt experienced shock; seemed very distant-all attentiveness disappeared.29 hrs after vax, pt was excessively sleepy.31 hrs after vax, pt died.
This spontaneous report as received from a pharmacist refers to 20 patients of unknown age and gender. The patients' medical history was not reported. On unknown dates, between 12-AUG-2015 and 12-FEB-2016, the patients were vaccinated with doses of improperly stored ZOSTAVAX (lot # L021608, expiration date reported as 10-SEP-2016, dose and route of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. Additional information is not expected because the reporter cannot be contacted.